| Tumor volume estimation and quasi-continuous administration for most effective bevacizumab therapy J Sápi, L Kovács, DA Drexler, P Kocsis, D Gajári, Z Sápi PloS one 10 (11), e0142190, 2015 | 140 | 2015 |
| Model-based angiogenic inhibition of tumor growth using modern robust control method L Kovács, A Szeles, J Sápi, DA Drexler, I Rudas, I Harmati, Z Sápi Computer Methods and Programs in Biomedicine 114 (3), e98-e110, 2014 | 61 | 2014 |
| Modeling of tumor growth incorporating the effects of necrosis and the effect of bevacizumab DA Drexler, J Sápi, L Kovács Complexity 2017 (1), 5985031, 2017 | 57 | 2017 |
| Model-based analysis and synthesis of tumor growth under angiogenic inhibition: a case study DA Drexler, L Kovács, J Sápi, I Harmati, Z Benyó IFAC Proceedings Volumes 44 (1), 3753-3758, 2011 | 56 | 2011 |
| Assessment and standardization of autonomous vehicles Á Takács, DA Drexler, P Galambos, IJ Rudas, T Haidegger 2018 IEEE 22nd International Conference on Intelligent Engineering Systems …, 2018 | 52 | 2018 |
| Tumor dynamics modeling based on formal reaction kinetics DA Drexler, T Ferenci, A Lovrics, L Kovács Acta Polytechnica Hungarica 16 (10), 31-44, 2019 | 40 | 2019 |
| Potential benefits of discrete-time controllerbased treatments over protocol-based cancer therapies J Sápi, DA Drexler, L Kovács Acta Polytechnica Hungarica 14 (1), 11-23, 2017 | 38 | 2017 |
| A minimal model of tumor growth with angiogenic inhibition using bevacizumab DA Drexler, J Sápi, L Kovács 2017 IEEE 15th International Symposium on Applied Machine Intelligence and …, 2017 | 36 | 2017 |
| Experimental data-driven tumor modeling for chemotherapy DA Drexler, T Ferenci, A Füredi, G Szakács, L Kovács IFAC-PapersOnLine 53 (2), 16245-16250, 2020 | 35 | 2020 |
| Handover Process of Autonomous Vehicles-technology and application challenges DA Drexler, A Takács, TD Nagy, T Haidegger Acta Polytechnica Hungarica 16 (9), 235-255, 2019 | 33 | 2019 |
| Qualitative analysis of tumor growth model under antiangiogenic therapy–choosing the effective operating point and design parameters for controller design J Sápi, DA Drexler, I Harmati, Z Sápi, L Kovács Optimal Control Applications and Methods 37 (5), 848-866, 2016 | 29 | 2016 |
| Linear state-feedback control synthesis of tumor growth control in antiangiogenic therapy J Sápi, DA Drexler, I Harmati, Z Sápi, L Kovács 2012 IEEE 10th International Symposium on Applied Machine Intelligence and …, 2012 | 25 | 2012 |
| Flat control of tumor growth with angiogenic inhibition DA Drexler, J Sápi, A Szeles, I Harmati, A Kovács, L Kovács 2012 7th IEEE International Symposium on Applied Computational Intelligence …, 2012 | 23 | 2012 |
| Positive nonlinear control of tumor growth using angiogenic inhibition DA Drexler, J Sápi, L Kovács IFAC-PapersOnLine 50 (1), 15068-15073, 2017 | 22 | 2017 |
| Global controllability of chemical reactions DA Drexler, J Tóth Journal of Mathematical Chemistry 54, 1327-1350, 2016 | 22 | 2016 |
| Solution of the closed-loop inverse kinematics algorithm using the Crank-Nicolson method DA Drexler 2016 IEEE 14th International Symposium on Applied Machine Intelligence and …, 2016 | 22 | 2016 |
| Modeling of tumor growth incorporating the effect of pegylated liposomal doxorubicin DA Drexler, T Ferenci, A Lovrics, L Kovács 2019 IEEE 23rd International Conference on Intelligent Engineering Systems …, 2019 | 21 | 2019 |
| Optimal discrete time control of antiangiogenic tumor therapy DA Drexler, J Sápi, L Kovács IFAC-PapersOnLine 50 (1), 13504-13509, 2017 | 18 | 2017 |
| State and parameter estimation of a mathematical carcinoma model under chemotherapeutic treatment M Siket, G Eigner, DA Drexler, I Rudas, L Kovács Applied Sciences 10 (24), 9046, 2020 | 17 | 2020 |
| H∞ control of nonlinear systems with positive input with application to antiangiogenic therapy DA Drexler, J Sápi, L Kovács IFAC-PapersOnLine 51 (25), 146-151, 2018 | 17 | 2018 |
Levente KovácsProfessor, Obuda University在 nik.uni-obuda.hu 的电子邮件经过验证
